News

All 2022 2021

CEECAT Capital completes the acquisition of Hermann Müller Chirurgie und Dental Instrumente

Founded in 1981 with a philosophy to excel through quality and service, Hermann Müller is the leading retractor company based in Tuttlingen, Germany. This philosophy remains the driving force behind the company today and has resulted in a company with a worldwide reputation of employing superior craftsmen working with high-quality German materials to manufacture reliable, durable and innovative surgical retractors and retractor systems of the highest available standard. Hermann Müller continues its R&D efforts to further improve its instruments as well to expand its product portfolio with new designs.

This has been the second investment of the Fund in the medical devices industry after the majority stake acquisition in Aygun Surgical Instruments, the second largest manufacturer of sterilization container systems in the world. With Hermann Müller’s buy-out, the Fund aims to establish a global medical device platform of excellence in innovation and manufacturing.

CEECAT Capital’s equity buyout fund targets growth equity investments in the small and mid-cap sector in Southeast Emerging Europe, focussing on majority buyout or minority investments with significant control rights. The Fund’s key themes are driven by core convergence, export competitiveness and import substitution in the region.  The €150mm Fund has made 6 investments to date deploying over €70mm.


Benjamin Mietz, CEO of Hermann Müller:

“Hermann Müller has a longstanding history of providing high-quality surgical devices and a strong position in the current dynamic market. I am excited to be a part of this strong alliance and look forward to enhancing our manufacturing excellence and continue to build on our long heritage with a close collaboration with our partners.”


Anthony Stalker, Partner of CEECAT Capital:

“We could not be more pleased to welcome a company with the history of Herman Muller into the CEECAT family. Lead by Benjamin we will continue the tradition of innovation and excellence based on research and development as we expand the company’s product portfolios to meet the demands of our customers.”